• $552.00
    Market Cap
  • -99.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
Income Statement
Total Operating Revenue
0
-100.00%
1,525
N/A
Cost of Revenue
0
-100.00%
72,686
N/A
Gross Profit
0
+100.00%
-71,161
N/A
Sales and Marketing Expense
81,547
-50.22%
163,810
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
1,983
-3.17%
2,048
N/A
Total Operating Expenses
-506,980
-143.09%
1.2M
N/A
Operating Profit
-567,829
-83.84%
-3.5M
N/A
Interest Income
183
N/A
N/A
N/A
Interest Expense
-60,412
+28.63%
-46,964
N/A
Interest Income and Expense and Net
-60,229
+28.25%
-46,964
N/A
Total Nonoperating Income and Expense
-60,849
-97.31%
-2.3M
N/A
Income before Taxes
-567,829
-83.84%
-3.5M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-541,583
-84.16%
-3.4M
N/A
Net Income from Continuing Operations Applicable to Common
-541,583
-84.58%
-3.5M
N/A
Basic EPS and Net Income
N/A
N/A
-0.01
N/A
Diluted EPS and Net Income
N/A
N/A
-0.01
N/A
Basic Weighted Average Shares
447.6M
+4.08%
430.1M
N/A
Diluted Weighted Average Shares
N/A
N/A
430.1M
N/A
Balance Sheet
Cash and Cash Equivalents
34,325
-80.33%
174,477
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
34,325
-80.33%
174,477
N/A
Total Current Assets
40,888
-77.36%
180,597
N/A
Accumulated Depreciation
0
-100.00%
1,206
N/A
Property and Plant and Equipment and Net
604,329
+9,472.77%
6,313
N/A
Total Long-Term Assets
604,329
+9,472.77%
6,313
N/A
Total Assets
645,217
+245.20%
186,910
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
725,000
+327.51%
169,588
N/A
Total Current Liabilities
835,540
+312.63%
202,492
N/A
Total Long-Term Debt
2.2M
0.00%
2.2M
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
Total Liabilities
835,540
+312.63%
202,492
N/A
Retained Earnings
-39.4M
+1.39%
-38.9M
N/A
Total Stockholders Equity
-190,323
+1,121.43%
-15,582
N/A
Total Shares Outstanding
451.7M
+1.97%
443.0M
N/A
Cash Flow
Cash from Operating Activities
-185,152
-74.73%
-732,649
N/A
Capital Expenditures
75,000
N/A
0
N/A
Cash from Investing Activities
-75,000
N/A
0
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
120,000
-74.47%
470,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
-130.17%
N/A
N/A
N/A
Return on Equity
526.05%
N/A
N/A
N/A
Revenue Growth
-100.00%
N/A
N/A
N/A
Current Ratio
0.05
N/A
N/A
N/A
Cash Ratio
0.04
N/A
N/A
N/A
Debt-to-Equity Ratio
-15.61
N/A
N/A
N/A
Debt-to-Assets Ratio
4.60
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow